Modalidades de imagem na osteonecrose dos maxilares relacionada à medicamentos: revisão de literatura by Yanaguizawa, Wellington Hideaki et al.
Clin Lab Res Den 2020: 1-7 ●  1
Oral Radiology




Imaging modalities in medication-related 
osteonecrosis of the jaw: a literature review
• Wellington Hideaki Yanaguizawa Department of Stomatology, School of Dentistry, University of São Paulo, São 
Paulo,  SP,  Brazil  • Solange Kobayashi Velasco Department  of  Stomatology,  School  of  Dentistry,  University  of 
São Paulo,  São Paulo,  SP, Brazil  • Rodrigo Lima Petersen Department  of Oral  Implantology,  School  of Dentistry, 
Fluminense Federal University, Rio de Janeiro, RJ, Brazil  • Fábio de Abreu Alves Department of Stomatology, School 
of Dentistry, University of São Paulo, São Paulo, SP, Brazil  • Marcelo Gusmão Paraiso Cavalcanti Department of 
Stomatology, School of Dentistry, University of São Paulo, São Paulo, SP, Brazil
 ABSTRACT | Osteonecrosis occurs by cellular death of the bone tissue due to an irreversible external factor. This disorder 
may be clinically unidentified in the early stages and result in degradation of the bone architectural structure, 
leading to pain, bone destruction, and loss of function. Thus, imaging exams become relevant to the recogni-
tion and definition of the bone necroses. The aim of this study was to review the literature on imaging exams 
frequently used for the diagnosis and evaluation of patients undergoing drug therapies associated with osteo-
necrosis of the jaw, such as panoramic radiography, computed tomography, magnetic resonance imaging and 
bone scintigraphy.
DESCRIPTORS   |  Osteonecrosis; Panoramic Radiography; X-Ray Computed Tomography; Magnetic Resonance Imaging; 
Radionuclide Imaging.
RESUMO   |  Modalidades de imagem na osteonecrose dos maxilares relacionada à medicamentos: revisão de literatura • A 
osteonecrose ocorre pela morte celular do tecido ósseo devido a um fator externo irreversível. Esse distúrbio pode não ser 
clinicamente identificado nos estágios iniciais gerando quadros de dor, destruição da arquitetura óssea e perda de função. 
Assim, os exames de imagem se tornam relevantes para o reconhecimento e a definição das necroses ósseas. O objetivo deste 
estudo foi revisar a literatura a respeito das diferentes modalidades de exames de imagem frequentemente utilizados para 
diagnóstico e avaliação de pacientes submetidos a terapias medicamentosas associadas à osteonecrose dos maxilares, como a 
radiografia panorâmica, tomografia computadorizada, ressonância magnética e cintilografia óssea.
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INTRODUCTION
Osteonecrosis – also known as avascular 
necrosis, ischemic necrosis or aseptic necrosis – is 
a pathological process caused by severe decrease in 
circulation in bone tissue resulting in the death of 
osteocytes and bone marrow cells. Osteonecrosis is 
not a disease-specific entity, but the common final 
course of many conditions leading to necrosis in any 
bone of the human body.1
In the maxillary region, osteonecrosis presents 
mainly as a result of two clinical situations: as a 
consequence of radiotherapy in the treatment of 
malignant neoplasms in head and neck regions, 
resulting in osteoradionecrosis, or as a side effect of 
drug therapy with antiangiogenic drugs, generating 
medication-related osteonecrosis of the jaw 
(MRONJ).1,2 This is considered a rare but potentially 
severe adverse effect, and may affect the quality of 
life of these patients.2
The correct analysis of MRONJ through imaging 
exams is essential to investigate and assess this 
disease. Imaging exams provide information to 
outline the most favorable treatment plan for the 
patient.3,4 Several studies exhibited MRONJ as 
incidental findings at different imaging exams, 
such as panoramic radiography (PR), computed 
tomography (CT), cone beam computed tomography 
(CBCT), magnetic resonance imaging (MRI), and 
scintigraphy.5–10 Thus, the purpose of this study was 
to present a literature review of different imaging 
exams that may be used to assess MRONJ patients.
MEDICATION-RELATED 
OSTEONECROSIS OF THE JAW (MRONJ)
In 2003, the American surgeon Marx reported 
and described MRONJ1. The condition was first 
named “Bisphosphonates-related osteonecrosis of the 
jaw” (BRONJ) because of its relation to the use of the 
class of anti-resorptive drugs called bisphosphonates, 
both oral (alendronate, ibandronate and risedronate) 
and intravenous (pamidronate and zolendronic 
acid).3,8 In 2014, the American Association of Oral 
and Maxillofacial Surgeons (AAOMS) recommended 
the replacement of the term BRONJ for “Medication-
related osteonecrosis of the jaw” (MRONJ), due to 
the increase in the number of cases of osteonecrosis 
of the jaws associated with other antiresorptive 
drugs, such as denosumab, and antiangiogenics, such 
as bevacizumab, sunitinib, sorafenib, imatinib and 
ziv-aflibercept, that is, not only bisphosphonates.2,11–14
These drugs have been used to control and treat 
many diseases, such as osteopenia and osteoporosis, 
hypercalcemia associated with bone metastasis of 
malignant neoplasms (especially multiple myeloma 
and metastatic bone cancer), fibrous dysplasia, 
Paget’s disease, and imperfect osteogenesis.13
The clinical diagnosis of MRONJ was defined by 
the AAOMS following three mandatory conditions: 
presence of bone exposure area or persistent intra- or 
extra-oral fistula for eight weeks or more in patients 
without prior history of radiation therapy who were 
or are being treated with antiresorptive and/or 
antiangiogenic agents..
Epidemiology varies depending on the population 
and the study. According to Kim et al., about 0.1% 
of patients that receive the medication orally and 
0.8 to 12% of patients that receive the medication 
intravenously may develop MRONJ.14
This type of osteonecrosis occurs most frequently 
associated with trauma, teeth extractions, 
implant surgery, and prostheses with stability 
or retention failures, associated to an infectious 
agent (periodontal or endodontic infection) or 
spontaneously.6,15 Furthermore, factors such as 
the time of administration, dose and route of 
administration of these drugs are closely linked to 
the risk of developing MRONJ.1,13
Clinically, MRONJ affects the posterior mandible 
region, and may present local pain symptoms, 
areas of mucosal ulceration, purulent edema and 
secretions, tooth mobility, paraesthesia, and intra 
or extraoral fistulae.13,14
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Treatment of osteonecrosis of maxillary bones is 
determined in consonance with the stage, severity 
of symptoms, functional impairment and general 
prognosis of the disease.4 However, treatment 
protocols are still widely discussed, ranging 
between more conservative treatments with use of 
mouthwashes with chlorhexidine 0.12% in cases 
where bone exposure is asymptomatic (stage 1) or 
antibiotic therapy when there are reports of pain 
with bone exposure (stage 2), and more invasive 
procedures, such as debridement at the site of the 
lesion, or surgical resection of the affected area 
(stage 3).15,16
IMAGING MODALITIES
Radiographically, osteonecroses caused by 
different types of antiresorptive drugs are very 
similar. The nonspecificity of these images leads 
to diagnostic criteria that do not consider the 
radiographic characteristics only.7,11,17 In addition, 
both methodologies and results in imaging 
studies among patients with MRONJ are greatly 
inconsistent, which has made it difficult to analyze 
the frequency of these radiographic findings.3,5,6,10 
Controversially, other studies have shown that 
imaging studies certainly have the potential to 
contribute significantly to both screening and initial 
diagnosis, as well as to the treatment and follow-up 
of these pathological processess.5,8,18
Panoramic radiography (PR)
PR is a radiographic exam widely used by 
professionals as initial assessment and follow-up of 
osteonecroses, since it provides a two-dimensional 
image involving all extension of both maxillary 
bones, as well as adjacent structures such as the 
nasal cavity and the maxillary sinuses, exposing 
the patient to a lower dose of radiation compared to 
three-dimensional exams.9 However, because PR is 
a two-dimensional projection, it suffers limitations 
such as magnification, superposition and distortion 
of anatomical structures.10 In cases where the 
lesions affect anterior regions, these lesions may 
be misdiagnosed due to the limitations of the 
examination.9 Moreover, factors such as patient 
position and proper acquisition technique influence 
the quality of the PR image.18
The most common images visualized in PR 
are radiopaque signs compatible with diffuse 
osteosclerosis and/or radiolucent signs compatible 
with osteolysis, present in the region of non-healed 
alveolus after tooth extractions.9,19 PR has also been 
used in the assessment of increased trabecular 
bone density, thickening of the mandibular canal 
cortices and osteosclerosis of the sinus floor caused 
by medications.12,20
Some studies correlate the increase in the lamina 
dura thickness with the periodontal space around 
the teeth and the occurrence of MRONJ; however, 
recent studies show that PR is not precise to 
demonstrate changes in the width of the periodontal 
space.21 Other two-dimensional examinations, such 
as periapical radiographs, exhibit images that allow 
a more detailed assessment of the thickening of 
the lamina dura, enlargement of the periodontal 
ligament and the density of the bone trabeculae, as 
well as information on carious lesions, periodontal 
or periapical disease, which are important factors to 
increase the risk of osteonecrosis.8
As the disease evolves, in stages 2 and 3, areas of 
bone with mottled appearance or bone sequestration 
and neoformation of periosteal bone, identical to 
those present in Garré’s osteomyelitis, may also be 
identified in this type of examination.5 According 
to Barragan et al.,22 the PR revealed the osteolytic 
lesions of osteonecrosis associated with the use of 
bisphosphonates, but it was neither able to show 
the real total extent of the lesion nor more detailed 
information of the area of bone sequestration as 
shown by the three-dimensional examinations.22
At a later stage, MRONJ may behave in a destructive 
manner, leading to areas of pathological fractures and 
Imaging modalities in medication-related osteonecrosis of the jaw
4 ● Clin Lab Res Den 2020: 1-7
cortical ruptures, but the PR examination may not 
reveal the lines of bone fracture and will not be able 
to reveal the involvement of the lingual and buccal 
cortices, making it impossible to correctly analyze the 
behavior of the lesion in relationship with adjacent 
structures.23
Radiographic findings of MRONJ found in PR are 
nonspecific, being more evident when a decrease of 
30-50% in bone mineral density occurs, that is, when 
bone involvement is more significant due to buccal 
/ lingual cortical thickness.9,23 Thus, the differential 
radiographic diagnosis by PR includes several other 
sclerotic, osteolytic and mixed lesions, such as chronic 
osteomyelitis, osteoradionecrosis, metastases, among 
others.5 If diagnostic information is ambiguous and 
further investigation of bone integrity is necessary, it 
is advisable to use three-dimensional examinations.
Computerized tomography (CT)
The high resolution of the helical computed 
tomography (CT) allows better assessment of the 
region affected by MRONJ, and it provides more 
information about cortical thickness, as well as 
involvement, bone marrow integrity, bone mineral 
density, relationship with the mandibular canal 
and other adjacent structures, irregularities of the 
alveolus after tooth extraction and the limits of bone 
sequestration.24
As well as PR, it is also possible to assess areas 
that are compatible with bone sclerosis, hypodense 
regions compatible with osteolysis, thickening of the 
lamina dura, periosteal reaction, bone sequestration 
and mandible fractures.17
Obinata et al. assessed the imaging features 
present in the MRONJ by comparing helical 
computed tomography (CT) and PR, and they found 
that CT provided more detailed information of 
osteolysis, osteosclerosis, bone sequestration, and 
periosteal reactions than in PR.23
Cone-Beam Computed Tomography (CBCT) is 
an advantageous option to assess the maxillofacial 
complex, since it emits less radiation and entails 
lower costs when compared to helical CT.25 However, 
the non-differentiation among soft tissues is a 
disadvantage.
Torres et al. evaluated three measurement 
techniques of images obtained by CBCT and concluded 
that at the mandible, cortical bone quantitative 
evaluation is a valuable method to be applied as early 
diagnostic manifestation. These authors observed 
that in patients exposed to bisphosphonates, bone 
alterations such as increase in thickness and volume 
of cortical bone occur prior to bone exposure.25 
Another study assessed the bone marrow and also 
found a significant alteration in the initial cases of the 
disease (stage 0), being a possible simple predictive 
indicator of bone exposures, since the CT values were 
described as reliable indicators of the predisposition 
to the development of the osteonecrosis.24
The imaging characteristics present in the 
MRONJ, even with the aid of the CBCT, may present 
differential diagnosis with several other diseases; 
the images of mixed radiodensity and periosteal 
reaction (aspect of “onion skin”) are also typical 
in osteomyelitis.26 Furthermore, MRONJ images 
may produce similar imaging aspects of metastatic 
lesions necrotic bone or areas submitted to radiation 
therapy in cancer patients. Those characteristics may 
generate confusion during the diagnosis process.27
Magnetic Resonance Imaging (MRI)
As with CT, magnetic resonance imaging can 
also be used to analyze the local characteristics 
and extent of osteonecrosis, as well as soft tissue 
involvement.8 Studies have shown that MRI can 
determine MRONJ involvement with more details 
when compared with CT scans.18
MRI can also be used in association with an 
intravenous contrast solution to assess the quality 
of the bone marrow, obtaining positive results in the 
diagnosis of initial lesions.26 Gadolinium contrast 
reveals a low signal in the images of T1 and T2, 
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suggesting a tissue of low water content, explained 
by the fact that the pattern of the necrotic bone has 
shortage of cells and vessels; besides, it allows the 
differentiation between areas of bone sequestrum 
and hyperemia. Gadolinium contrast presents higher 
concentration in the latter.7
However, because it is a high-cost and difficult-to-
access exam, radiographs and CBCT remain the most 
commonly used imaging exams for bone assessment 
and follow-up of osteonecroses.
Bone scintigraphy
Bone scintigraphy is an examination capable 
of detecting even small areas of bone necrosis by 
radioisotope uptake by exhibiting marking areas 
in the periphery and low radioactive uptake in the 
center, probably due to the lower osteoblastic activity 
and absence of blood supply in the area due to cell 
necrosis.28 As a result, this is the most sensitive test 
for the detection of subclinical lesions and initial 
stages in maxillary bones.15
Figure 1 | Axial (A), Sagittal (B) and Coronal (C) planes on Com-
puted  Tomography  images  of  a  MRONJ  case  involving  palatine 
bone (arrows).
Figure 2 | Bone scintigraphy  (A), Panoramic  (B),  coronal  (C) and 
sagittal  radiograph  (D),  and  Cone-Beam  Computed  Tomography 
images (K arrow = bone resorption, C arrow = bone sequestrum) of a 
MRONJ case.
However, because it is an image examination 
of the whole skeleton, its resolution turns out to 
be of poor quality; in addition, the markers bind 
mainly in cells of greater metabolic activity. This 
aspect leads to a poor imaging differentiation 
among osteonecroses, tumors, bone metastases, 
osteomyelitis or bone inflammatory process, thus 
indicating that this examination modality has low 
specificity.26
CONCLUSIONS
MRONJ is usually diagnosed late, presenting 
bone exposure in the oral cavity and a combination 
of different types of imaging tests such as panoramic 
radiography, computed tomography, magnetic 
resonance imaging and bone scintigraphy may be 
relevant to identify these osteonecroses in the jaws. The 
costs of these methods vary greatly, as well as their 
accuracy and the information they provide. PR, CT and 
MRI are considered important examinations in the 
general evaluation of the lesions, the latter two being 
important in assessing the limits of the disease. MRI, 
as well as BS, may be useful in detecting subclinical 
osteonecrosis when the bone is not exposed. However, 
BS has no specificity and low resolution.
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